Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
12/2005
12/01/2005US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
12/01/2005US20050267280 Lactone bearing absorbable polymers
12/01/2005US20050267182 Urea derivatives as FLT-3 modulators
12/01/2005US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
12/01/2005US20050267071 Inhibitors of coronavirus protease and methods of use thereof
12/01/2005US20050267056 Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives
12/01/2005US20050267033 Multi-dose erythropoietin formulations
12/01/2005US20050267021 Cystatin C as an antagonist of TGF-beta and methods related thereto
12/01/2005DE102004023187A1 Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie Identifying surface-associated antigens for tumor diagnosis and therapy
11/2005
11/30/2005EP1599581A2 Production of a live vaccine directed against influenza viruses
11/30/2005EP1599454A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments
11/30/2005EP1599231A2 Treatment of pain through expression of opioid receptors
11/30/2005EP1599228A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
11/30/2005EP1599223A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins
11/30/2005EP1599209A2 Inhalation composition
11/30/2005EP1599208A2 Antiglucocorticoids for the treatment of postpartum psychosis
11/30/2005EP1599200A2 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
11/30/2005EP1599197A2 The use of antimuscarinic drugs
11/30/2005EP1599196A2 Combination therapies for the treatment of cancer
11/30/2005EP1599190A2 Controlled release modifying complex and pharmaceutical compositions thereof
11/30/2005EP1599175A2 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
11/30/2005EP1599174A2 Novel compounds
11/30/2005EP1599171A2 Combination therapy for treating alphavirus infection and liver fibrosis
11/30/2005EP1599170A2 Human lymphocyte vaccine adjuvant
11/30/2005EP1599168A2 Relaxin3-gpcr135 complexes and their production and use
11/30/2005EP1599165A2 The use of gcc ligands
11/30/2005EP1599164A2 Methods for treating, preventing and detecting helicobacter infection
11/30/2005EP1599141A2 Ultrasonically enhanced saline treatment for burn damaged skin
11/30/2005CN1703426A Humanized antibodies that recognize beta amyloid peptide
11/30/2005CN1703399A Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
11/30/2005CN1703238A Recombinant intracellular pathogen immunogenic compositions and methods for use
11/30/2005CN1703237A Treatment of allergic conditions by use of il 21
11/30/2005CN1703232A Method of treating diabetes using plant argyrolobium roseum extract
11/30/2005CN1703205A Extended, controlled-release pharmaceutical compositions using charged polymers
11/30/2005CN1703151A Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229350C New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
11/30/2005CN1229349C Pyridine-3-carboxylic acid derivative
11/30/2005CN1229112C Rapid onset preparation
11/29/2005US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system
11/29/2005US6969721 Tricyclic 2-pyridone compounds of formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to
11/29/2005US6969515 Comprises proteolytic enzymes; free of plasminogen activator
11/29/2005US6969367 Extracorporeal pathogen reduction system
11/29/2005CA2164704C Use of cobalamins for topical treatment of dermatological illnesses
11/24/2005WO2005110497A1 Imaging of tumors and metastases using a gelatinase targeting peptide comprising the structure ctthwgftlc.
11/24/2005WO2005110347A1 Composition, compising hydrofluoric acid, for inhibiting dental erosion
11/24/2005WO2005110338A2 Identification of surface-associated antigens for tumor diagnosis and therapy
11/24/2005WO2005046604A3 Heteroaryl-hydrazone compounds
11/24/2005WO2005041893A3 Detection of acute myocardial infarction biomarkers
11/24/2005WO2005041887A3 Pigment epithelium-derived factor, novel biological activity and methods of use
11/24/2005WO2005041875A3 Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications
11/24/2005WO2005039498A3 Methods of treating cancer with hdac inhibitors
11/24/2005WO2005037230A3 Compositions and methods for treating heart failure
11/24/2005WO2005034871A3 Methods for treating diseases and conditions with inverse agonists
11/24/2005WO2005032489A3 Coated metal pyrithione particles for treatment of microorganisms
11/24/2005WO2005030145A3 Composition and pharmacology of novel alpha-6-containing nicotinic acetylcholine receptors
11/24/2005WO2005016249A3 Compositions of a chromene or phenyl acetic acid cyclooxygenase-2 selective inhibitor and an ace inhibitor for the treatment of central nervous system damage
11/24/2005WO2005009357A3 Controlled release compositions
11/24/2005WO2005002499A3 A method and therapeutic platelets
11/24/2005WO2005000246A3 Methods and compositions for treating rheumatoid arthritis
11/24/2005WO2005000205A3 Methods and compositions for modulating serum cortisol levels
11/24/2005WO2004103271A3 Disease prevention and vaccination prior to thymic reactivations
11/24/2005WO2004091525A3 Morpholino imaging and therapy via amplification targeting
11/24/2005WO2004089313A3 Novel olanzapine forms and related methods of treatment
11/24/2005US20050261338 Beta2-adrenergic receptor agonists
11/24/2005US20050261320 Compounds and methods for the treatment of cancer
11/24/2005US20050261315 tyrosine kinase inhibitors such as N-(3-tert-butylisoxazol-5-yl)-2-(4-(benzyloxy)phenyl)acetamide, used for treating and preventing conditions and diseases, such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
11/24/2005US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
11/24/2005US20050261218 Oligomeric compounds and compositions for use in modulation small non-coding RNAs
11/24/2005US20050260683 Methods for diagnosing and treating pre-term labor
11/24/2005US20050260612 Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials
11/24/2005US20050260277 Method and formula for anti-tumor and anti-matastatic effect
11/24/2005US20050260145 Oil soluble compositions
11/24/2005US20050258373 Boron coated straw neutron detector
11/24/2005CA2820168A1 Identification of surface-associated antigens for tumor diagnosis and therapy
11/24/2005CA2566408A1 Composition, comprising hydrofluoric acid, for inhibiting dental erosion
11/24/2005CA2563671A1 Identification of surface-associated antigens for tumor diagnosis and therapy
11/23/2005EP1598069A2 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
11/23/2005EP1598054A2 Method of suppressing appetite
11/23/2005EP1597274A2 Hsp60 from arthrobacter
11/23/2005EP1597267A2 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues
11/23/2005EP1597265A2 Glycosolated enkephalin agents
11/23/2005EP1597260A1 Triazole compounds useful in therapy
11/23/2005EP1597238A1 Hiv replication inhibiting pyrimidines and triazines
11/23/2005EP1596882A2 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins
11/23/2005EP1596878A2 Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors
11/23/2005EP1596875A2 Tertiary amine functional complex polyester polymers and methods of production and use
11/23/2005EP1596869A2 Novel cocrystallization
11/23/2005EP1596867A2 Treatment of psychosis with a muscarinic m1 receptor ectopic activator
11/23/2005EP1596860A2 Novel compounds
11/23/2005EP1596854A2 Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions
11/23/2005EP1596843A2 Slowly digestible starch
11/23/2005EP1596839A2 Semi-solid immediate-release oral formulations comprising an anticancer hydrophobic agent, a polyglycolised glyceride and a hydrophilic carrier
11/23/2005EP1596823A2 A stable ophthalmic composition
11/23/2005EP1596822A2 A low dose corticosteroid composition
11/23/2005EP1596821A2 Synergistic compositions and methods for potentiating anti-oxidative activity
11/23/2005EP1596815A2 Composition and methods for inhibiting cell survival
11/23/2005EP1596813A2 Lung-expressed polypeptides
11/23/2005EP1596811A2 Compositions and methods to modulate immune and inflammatory responses
11/23/2005EP1596809A2 Abeta binding molecules
1 ... 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 ... 295